Prosecution Insights
Last updated: April 19, 2026

Examiner: LIRIANO, MELISSA LIZETTE

Tech Center 1600 • Art Units: 1677 1678

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
8
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

21.3%
§101 Eligibility
23.4%
§102 Novelty
25.5%
§103 Obviousness
17.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18185624 METHODS AND SYSTEMS FOR ANALYZING POLYPEPTIDE VARIANTS Non-Final OA Regeneron Pharmaceuticals, Inc.
18351263 ANALYTE DETECTION USING FLUOROGENIC PROBES OR MULTIPLEX TECHNOLOGIES Non-Final OA The Regents of the University of Michigan
18454527 MACHINE LEARNING-BASED ASN GROUPING FOR PREDICTING CERVICAL CANCER PROGNOSIS AND CHEMORADIOTHERAPY RESPONSE USING ATP5H, SCP3, AND NANOG Non-Final OA INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
17350822 METHODS FOR DETECTING AN ANALYTE USING STRUCTURE SWITCHING BINDING AGENTS Non-Final OA Roche Sequencing Solutions, Inc.
18340625 DEVICE FOR TESTING MULTIPLE ANALYTES IN LIQUID SAMPLE THROUGH LATERAL FLOW Non-Final OA Zhejiang Orient Gene Biotech Co.,Ltd

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month